NGMUSD

Ngm Biopharmaceuticals INC

+$19.7M

Net Activity

Institutions Holding

75

Popularity Rank

#4564

Avg Weight

0.26%

Total Value

$54.8M

Ownership Trend

75 institutions currently hold NGMUSD, with 12 net buyers and 16 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2024)

Neutral

Based on recent trading activity

Net Selling Institutions

16

Net Buying Institutions

12

Key Holders

View all 75 holding institutions

Quarterly Activity

Recent Activity

+$3.2M

Total Buy Value

$4.9M

Total Sell Value

New buy6
Trim9
Add6
Sold out7

12

Net Buyers

16

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding NGM BIOPHARMACEUTICALS INC (NGMUSD)?
Major stakeholders currently include Column Group LLC ($28.8M), BlackRock Inc. ($4.8M), Vanguard Group INC ($3.7M). Based on the latest 13F filings, there are a total of 75 tracked investment funds and institutions maintaining positions in NGMUSD.
What is the overall institutional sentiment toward NGMUSD recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $19.7M, driven by 12 managers accumulating shares while 16 reduced their exposure.
Which institutions have been selling or reducing their NGMUSD positions?
In the latest period, 9 funds trimmed their holdings, and 7 managers completely exited their positions. The aggregate reported sell value was $4.9M.
Are there any notable investors adding NGMUSD to their portfolios?
Yes, buying activity remains notable. 6 institutions opened new positions in {ticker}, and 6 existing holders added to their shares. The total reported buy value for the quarter amounted to $3.2M.

Related Stocks